467 related articles for article (PubMed ID: 32992823)
1. Molecular Insights and Emerging Strategies for Treatment of Metastatic Uveal Melanoma.
Mallone F; Sacchetti M; Lambiase A; Moramarco A
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32992823
[TBL] [Abstract][Full Text] [Related]
2. Liver metastasis in uveal melanoma - treatment options and clinical outcome.
Kaštelan S; Mrazovac Zimak D; Ivanković M; Marković I; Gverović Antunica A
Front Biosci (Landmark Ed); 2022 Feb; 27(2):72. PubMed ID: 35227015
[TBL] [Abstract][Full Text] [Related]
3. New Insights into Molecular Oncogenesis and Therapy of Uveal Melanoma.
Violanti SS; Bononi I; Gallenga CE; Martini F; Tognon M; Perri P
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31109147
[TBL] [Abstract][Full Text] [Related]
4. Role of immune checkpoint inhibitors and novel immunotherapies in uveal melanoma.
Jindal V
Chin Clin Oncol; 2018 Feb; 7(1):8. PubMed ID: 29486567
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances and Challenges in Uveal Melanoma Immunotherapy.
Fu Y; Xiao W; Mao Y
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804863
[TBL] [Abstract][Full Text] [Related]
6. Uveal melanoma: Recent advances in immunotherapy.
Sorrentino FS; De Rosa F; Di Terlizzi P; Toneatto G; Gabai A; Finocchio L; Salati C; Spadea L; Zeppieri M
World J Clin Oncol; 2024 Jan; 15(1):23-31. PubMed ID: 38292657
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions.
Lamas NJ; Martel A; Nahon-Estève S; Goffinet S; Macocco A; Bertolotto C; Lassalle S; Hofman P
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008260
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Uveal Melanoma.
Shoushtari AN; Carvajal RD
Cancer Treat Res; 2016; 167():281-93. PubMed ID: 26601868
[TBL] [Abstract][Full Text] [Related]
9. The Role of Immune Checkpoint Blockade in Uveal Melanoma.
Wessely A; Steeb T; Erdmann M; Heinzerling L; Vera J; Schlaak M; Berking C; Heppt MV
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013269
[TBL] [Abstract][Full Text] [Related]
10. So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020.
Rodrigues M; Koning L; Coupland SE; Jochemsen AG; Marais R; Stern MH; Valente A; Barnhill R; Cassoux N; Evans A; Galloway I; Jager MJ; Kapiteijn E; Romanowska-Dixon B; Ryll B; Roman-Roman S; Piperno-Neumann S;
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31336679
[TBL] [Abstract][Full Text] [Related]
11. Systemic and liver-directed therapies in metastatic uveal melanoma: state-of-the-art and novel perspectives.
Comito F; Marchese PV; Ricci AD; Tober N; Peterle C; Sperandi F; Melotti B
Future Oncol; 2021 Nov; 17(33):4583-4606. PubMed ID: 34431316
[TBL] [Abstract][Full Text] [Related]
12. Recent approaches for the treatment of uveal melanoma: Opportunities and challenges.
Khan SA; Almalki WH; Arora S; Kesharwani P
Crit Rev Oncol Hematol; 2024 Jan; 193():104218. PubMed ID: 38040071
[TBL] [Abstract][Full Text] [Related]
13. Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry.
Jochems A; van der Kooij MK; Fiocco M; Schouwenburg MG; Aarts MJ; van Akkooi AC; van den Berkmortel FWPJ; Blank CU; van den Eertwegh AJM; Franken MG; de Groot JB; Haanen JBAG; Hospers GAP; Koornstra RH; Kruit WHJ; Louwman M; Piersma D; van Rijn RS; Suijkerbuijk KPM; Ten Tije AJ; Vreugdenhil G; Wouters MWJM; van Zeijl MCT; van der Hoeven KJM; Kapiteijn E
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31323802
[TBL] [Abstract][Full Text] [Related]
14. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
15. Combination of Immune Checkpoint Inhibitors and Liver-Specific Therapies in Liver-Metastatic Uveal Melanoma: Can We Thus Overcome Its High Resistance?
Blomen CL; Kött J; Hartung TI; Torster LK; Gebhardt C
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34945010
[TBL] [Abstract][Full Text] [Related]
16. Uveal melanoma: laboratory advances and new frontiers in patient care.
Xu TT; Moser JC; Dalvin LA
Curr Opin Ophthalmol; 2021 May; 32(3):301-308. PubMed ID: 33606406
[TBL] [Abstract][Full Text] [Related]
17. Applying Single-Cell Technology in Uveal Melanomas: Current Trends and Perspectives for Improving Uveal Melanoma Metastasis Surveillance and Tumor Profiling.
Wang MM; Chen C; Lynn MN; Figueiredo CR; Tan WJ; Lim TS; Coupland SE; Chan ASY
Front Mol Biosci; 2020; 7():611584. PubMed ID: 33585560
[TBL] [Abstract][Full Text] [Related]
18. Clinical Trials in Metastatic Uveal Melanoma: Immunotherapy.
Orloff M
Ocul Oncol Pathol; 2021 Jun; 7(3):168-176. PubMed ID: 34307327
[TBL] [Abstract][Full Text] [Related]
19. Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives.
Buder K; Gesierich A; Gelbrich G; Goebeler M
Cancer Med; 2013 Oct; 2(5):674-86. PubMed ID: 24403233
[TBL] [Abstract][Full Text] [Related]
20. Treatment of uveal melanoma: where are we now?
Yang J; Manson DK; Marr BP; Carvajal RD
Ther Adv Med Oncol; 2018; 10():1758834018757175. PubMed ID: 29497459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
